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Introduction
Primary tooth endodontic filling materials are re-
quired to be resorbable and nontoxic to periapical 
tissues and the permanent tooth germ. According 
to reports by manufacturers of these materials, 
many different kinds of filling materials matching 
such requirements are currently available on the 
Background/purpose: Primary tooth endodontic filling materials should be bio-
compatible with periodontal tissue. The purpose of this study was to analyze the 
biologic effects of different endodontic filling materials for primary teeth on a human 
osteosarcoma cell line (U2OS).
Materials and methods: Experimental groups comprised different mixes of endo-
dontic filling materials: zinc oxide-eugenol (ZnOE) + formocresol (FC); calcium hy-
droxide [Ca(OH)2] + FC; Ca(OH)2 + iodoform + deionized water; Ca(OH)2 + iodoform + 
camphorated parachlorophenol (CPC); Ca(OH)2 + CPC; and Vitapex. These were pre-
pared and used to fill special glass rings, which were subsequently eluted in 10 mL of 
cell culture medium at 37ºC in a 5% carbon dioxide-in-air atmosphere for 24 hours. 
Cell culture medium alone was used as the control group. A DNA fragmentation 
assay was performed to determine the genotoxicity of each mix of materials. The 
level of cyclooxygenase (COX)-2 protein expression, the extent of dental material-
elicited inflammation of U2OS cells, and the degree of mitogen-activated protein 
(MAP) kinase expression were determined using Western blot analysis.
Results: The results revealed that no DNA breakage was apparent after U2OS cells 
were treated with the various materials. COX-2 band expression dramatically declined 
in the ZnOE + FC group compared with the control group, although high levels of 
expression of the COX-2 band were noted for the Ca(OH)2 + FC and Ca(OH)2 + iodo-
form + CPC groups. Band levels of extracellular signal-regulated kinase (ERK-1 and ERK-2) 
expression declined in the ZnOE + FC and Ca(OH)2 + CPC groups compared with the 
control group. p53 and caspase-3 protein bands appeared in all experimental groups.
Conclusion: The cytotoxic mechanism of endodontic filling materials on U2OS cells 
was induced by means of activation of the p53 and caspase-3 apoptosis signaling 
pathways.
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market. Such materials include calcium hydroxide 
[Ca(OH)2], zinc oxide (ZnO), ZnO-eugenol (ZnOE) 
either with or without the incorporation of formo-
cresol (FC), and iodoform pastes, such as Kri-1 paste 
(a mixture of iodoform and camphorated parachlo-
rophenol [CPC]) and Vitapex paste [a mixture of 
40.4% iodoform, 30.3% Ca(OH)2, and 22.4% silicone]. 
The respective manufacturers all claim that these 
materials are biocompatible.
The use of ZnOE or ZnO to fill root canals of 
primary teeth was first described by Sweet in 1930. 
Such agents have been demonstrated to have anti-
bacterial effects against pure cultures of certain 
bacteria, as reported by a number of studies.1,2 
However, Prashar et al.3 reported that clove oil was 
highly cytotoxic to human skin cells at concentra-
tions as low as 0.03% (v/v) with up to 73% of this ef-
fect being attributable to eugenol. Eugenol and FC 
components have been demonstrated to be toxic 
to cultured mammalian cells.3,4 Similar cytotoxicity 
results were found in our previous work, and the ad-
dition of eugenol or FC to different endodontic fill-
ing materials revealed different degrees of toxicity 
toward a human osteosarcoma cell line (U2OS).5
The results of an animal study indicated that pu-
rified eugenol elicited less tissue necrosis and in-
flammation at all different exposure levels and for 
all different exposure times than was the case for 
commercially available eugenol. The degree of in-
flammation elicited by various ZnOE mixtures was 
strongly influenced by the quantity of free eugenol 
present in the mixture.6 Eugenol compounds have 
various biologic effects including both antioxidant 
and anti-inflammatory activities.7−10
In 1997, Fuks et al.11 compared the pulpal re-
sponses of baboon teeth to ferric sulfate and FC. 
Biologic outcomes of both tested chemical agents 
appeared to be equivalent 6 weeks after exposure 
to these materials, with 60% of the teeth from 
each test group showing mild inflammation. Cotes 
et al.12 confirmed a similar inflammatory response 
of rat teeth after exposure to ferric sulfate and FC. 
Two studies of histologic impacts of FC upon dental 
pulp following pulpotomy showed chronic inflamma-
tion and necrosis of the radicular pulp,13,14 while 
other animal models revealed the systemic distri-
bution of FC from the pulpotomy site15 and allergic 
and/or mutagenic properties of formaldehyde.16
The eukaryotic transcription factor nuclear factor 
(NF)-κB plays a primary role in general inflamma-
tion and the immune response.17 NF-κB is a critical 
regulator of cyclooxygenase (COX)-2 expression in 
many different cell lines.17,18 The intracellular sig-
naling cascades controlling NF-κB activation are 
reported to be highly complex and involve a distinct 
set of kinases. Of the potential protein kinases in-
volved in the activation of NF-κB, the activity of 
mitogen-activated protein (MAP) kinases, such as 
extracellular signal-regulated kinase (ERK), p38 
and c-Jun N-terminal kinase/stress-activated pro-
tein kinase signaling pathways, have been well 
characterized.19,20
Our purpose was to analyze the biologic effects 
of different endodontic filling materials upon primary 
teeth. We attempted to evaluate the genotoxicity 
of these dental materials, their ability to stimulate 
an inflammatory reaction in test cells, and the pos-
sible mechanisms of their action in a U2OS.
Materials and methods
Materials and sample preparation
Following our previous investigation,5 the experi-
mental group comprised six different endodontic 
filling material formulations, as listed in Table 1. 
These different endodontic filling material formu-
lations were: (1) 6 g ZnO + 1 mL eugenol + 1 mL FC; 
(2) 6 g Ca(OH)2 + 1 mL FC; (3) 6 g Ca(OH)2 + 0.6 g io-
doform + 2 mL deionized water; (4) 6 g Ca(OH)2 + 0.6 g 
iodoform + 2 mL CPC; (5) 6 g Ca(OH)2 + 2 mL CPC; and 
(6) Vitapex (Neo Dental Chemical, Tokyo, Japan), 
a non-mixing type of material which was tested as 
Table 1. Experimental groups and the composition of the experimental root filling materials
 Material Composition  Dilute solution  Immersion time (hr)
Control group Medium McCoy’s medium NA NA
Group 2 Vitapex [Ca(OH)2 +  0.5 g 1 mL McCoy’s medium 24
  iodoform + silicone oil]
Group 3 ZnOE + FC 6 g/1 mL/1 mL 1 mL McCoy’s medium 24
Group 4 Ca(OH)2 + FC 6 g/1 mL 1 mL McCoy’s medium 24
Group 5 Ca(OH)2 + iodoform 6 g/0.6 g 1 mL McCoy’s medium 24
Group 6 Ca(OH)2 + iodoform + CPC 6 g/0.6 g/2 mL 1 mL McCoy’s medium 24
Group 7 Ca(OH)2 + CPC 6 g/2 mL 1 mL McCoy’s medium 24
Ca(OH)2 = calcium hydroxide; ZnOE = zinc oxide-eugenol; FC = formocresol; CPC = camphorated parachlorophenol.
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supplied by the manufacturer. Freshly mixed ma-
terials were placed in glass rings (2 mm in height, 
6 mm in diameter) and allowed to set for 24 hours 
at 37°C in a humidified chamber. Five samples of 
each endodontic filling material were then eluted 
in 10 mL of cell culture medium for 24 hours at 37°C, 
in a 5% carbon dioxide-in-air atmosphere. Test mate-
rials were diluted by adding an appropriate volume 
of culture medium to achieve a final concentration 
of 5 μL/mL. Culture medium with no additional ex-
perimental material served as the control group.
DNA fragmentation assay
The DNA fragmentation assay was based on the 
method of Fady et al.21 as described previously. 
Following treatment with selected endodontic fill-
ing materials, U2OS cells were lysed in 10mM Tris-
HCl (pH 7.5), 100mM ethylenediaminetetraacetic 
acid (EDTA), 0.5% sodium dodecyl sulfate (SDS), and 
100 μg/mL of proteinase K for a period of 18 hours 
at 37°C. DNA was then extracted twice with phenol/
chloroform/isoamyl alcohol, precipitated in ethanol, 
centrifuged (30 minutes at 10,000g), and re-suspended 
in Tris-EDTA buffer containing ribonuclease at a 
concentration of 100 μg/mL for a period of 1 hour 
at 37°C. Following a second extraction in phenol/
chloroform/isoamyl alcohol, and precipitation in 70% 
ethanol, the DNA was suspended in Tris-EDTA buffer, 
and 5−10 μg of DNA per lane was electrophoresed in 
a 1% agarose gel for 2 hours at a potential difference 
of 45 V. Gels were subsequently visualized following 
treatment with ethidium bromide.
Inflammatory protein and COX-2 
protein evaluation
Using Western blot analysis, cell lysates derived 
from U2OS cell cultures were collected. In this 
assay, lipopolysaccharide was added to U2OS cells 
as a positive control. McCoy’s medium was used as 
a negative control. The protein assay was performed 
as described in our previous study.22 Briefly, U2OS 
cells were solubilized in SDS-solubilization buffer 
(1mM MgCl2, 50mM Tris-HCl, 5mM EDTA, pH 7.5, 0.5% 
Triton X-100, 2mM phenylmethylsulfonyl fluoride 
[PMSF], and 1mM N-ethylmaleimide) for 30 minutes 
on ice. Following this, cell lysates were centrifuged 
at 12,000g and 4°C, and the protein concentrations 
were determined using Bradford reagent; bovine 
serum albumin (BSA) was used as the standard. 
Equivalent amounts of total protein per sample of 
cell extracts were run on a 10% SDS polyacrylamide 
gel electrophoresis (PAGE) assay and immediately 
transferred to nitrocellulose membranes. The mem-
branes were then blocked with phosphate-buffered 
saline (PBS) containing 3% BSA for 2 hours, rinsed, 
and incubated with the primary anti-COX-2 antibody 
diluted 1:1000 in PBS containing 0.05% Tween 20 for 
a period of 2 hours. Follow ing three washes with 
Tween 20 for 10 minutes each, the membranes were 
incubated for 1 hour with a biotinylated secondary 
antibody (polyclonal anti-rabbit immunoglobulin G 
[IgG] for COX-2) diluted 1:2000 in the same buffer 
used for washing. Then membranes were washed 
again as described above and treated with a 1:2000 
streptavidin-peroxidase solution for 30 minutes. A 
β-actin antibody was used as the control for Western 
blotting. Following a series of three further washing 
steps, the extent of the immunologic reactions which 
had taken place was determined by diaminobenzi-
dine. The relative intensities of the obtained bands 
were determined with a densitometer (AlphaImager 
2000, Alpha Innotech, San Leandro, CA, USA).
Analysis of MAP kinases: ERK, p53, and 
caspase-3
After U2OS cells had been exposed to endodontic 
filling materials, culture plates were washed once 
with cold PBS. Five million U2OS cells were col-
lected and lysed in 50 μL of lysis buffer (1% Triton 
X-100, 0.5% NP40, 10mM EGTA, 0.2mM Na3VO4, 
0.2mM NaF, and 0.2mM PMSF) for a period of 30 
minutes. Cell lysates were cleared at 15,000g for 
a period of 15 minutes at 4°C. Twenty-five micro-
grams of protein from each sample was collected 
and boiled for 5 minutes in 1 × SDS gel-loading buffer 
(125mM Tris, pH 6.8, 5% glycerol, 28mM SDS, 1% 
β-mercaptoethanol, and 0.006% bromophenol blue). 
Proteins were separated by 12.5% SDS-PAGE and 
transferred onto polyvinylidene difluoride mem-
branes. The membranes were blocked for 1 hour at 
room temperature in 3% BSA, 5% nonfat dried milk, 
10mM Tris (pH 7.5), 100mM NaCl, and 0.1% Tween 20. 
Following four washes in TBS-T buffer (10mM Tris, 
pH 7.5, 70mM NaCl, and 0.1% Tween), the membranes 
were incubated with 0.5 μg/mL rabbit antibody over-
night. Following four further washes with TBS-T buffer, 
the membrane was overlain with a second antibody 
for 1 hour, and then washed with TBS-T buffer for 
20 minutes. The resultant films were scanned and 
quantified using a densitometer and the SCION image 
program (Scion, Frederick, MD, USA).
Results
Cell morphology
After treating U2OS cells with different endodontic 
filling materials for different time periods, there 
were changes in U2OS cell morphology, as pre-
sented in Fig. 1. U2OS cells in the ZnOE + FC group 
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appeared to have become condensed, revealing 
cell separation and a decline in cell number after 
treatment for 12 hours. Cell death followed treat-
ment of cells with Ca(OH)2  + iodoform + CPC for 24 
hours. Virtually all cells in the Ca(OH)2  + CPC group 
became somewhat star-shaped and quite condensed 
following 12 hours of treatment; and following 24 
hours of treatment, significant cell separation was 
apparent. For the remaining experimental groups 
(groups in lanes 1, 2, 4 and 5 of Fig. 1), cell morphol-
ogy post-treatment appeared to be normal with no 
significant changes in cell growth.
DNA fragmentation assay
No DNA-ladder bands appeared following the gel 
assay in any experimental group or the control group 
(Fig. 2). The DNA-breakage assay for U2OS cells re-
vealed no ladders after treatment with the various 
dental materials, suggesting that after exposure to 
those dental materials, there was no evidence of 
any DNA fragmentation.
COX-2 protein expression
The strength of U2OS cell COX-2 protein expres-
sion (in order from high to low expression) for the 
six experimental groups in Fig. 3 was: lane 6 > lane 
4 > lane 5 > lane 7 > lane 2 > lane 3. The level of COX-2 
band expression in U2OS cells from the ZnOE + FC 
group was virtually zero, but COX-2 expression in 
the Ca(OH)2 + FC and Ca(OH)2 + iodoform + CPC groups 
was quite high (Fig. 3).
MAP kinase expression
ERK (ERK-1, and ERK-2) kinase expression in U2OS 
cells from the ZnOE + FC and Ca(OH)2 + CPC groups 
was substantially lower than that in the control 
group. p53 and caspase-3 protein bands appeared 
in the Western blot assay of all experimental groups 
(Fig. 4).
Discussion
Endodontic filling materials and 
genotoxicity
The results of the DNA-fragmentation study showed 
that none of the tested formulations of endodontic 
filling materials were genotoxic to cultured U2OS 
cells (Fig. 2). Similar results were reported in a study 
by Ribeiro et al.23 Their findings suggested that FC, 
paramonochlorophenol and Ca(OH)2 do not promote 
DNA damage in L5178Y mouse lymphoma cells.
Although the eugenol and FC components of the 
tested endodontic filling materials were previously 
shown to be toxic agents in cultured mammalian 
cells,3,4 these materials do not appear to be geno-
toxic to L5178Y mouse lymphoma cells or U2OS 
cells.23 The lack of genotoxicity of FC on cell lines 
might be related to the material containing cresol, 
because cresol is a chemical inhibitor of reactive 
oxygen species synthesis.24
Eugenol was found to be genotoxic to a cultured 
human hepatoma cell line (Hep G2) in an in vitro 
Group
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Fig. 1 U2OS cell morphologic changes following treatment with different formulations of endodontic filling materials 
at different time intervals (1, 3, 6, 12 and 24 hours of exposure to the test dental materials). Lane 1 represents the 
control group, lane 2 the Vitapex group, lane 3 the zinc oxide-eugenol (ZnOE) + formocresol (FC) group, lane 4 the 
Ca(OH)2 + FC group, lane 5 the Ca(OH)2 + iodoform group, lane 6 the Ca(OH)2 + iodoform + camphorated parachloroph-
enol (CPC) group, and lane 7 the Ca(OH)2 + CPC group. 
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study.25 A similar finding was reported by Maralhas 
et al.26 who studied the effects of eugenol upon 
V79 cells using a chromosomal-aberration analysis. 
In contrast to those results, our results demonstrated 
no DNA fragmentation in U2OS cells.
Ca(OH)2 did not exhibit genotoxicity toward as-
trocytes, as reported in our previous comet assay.27 
Similarly, Ca(OH)2 did not induce DNA damage in 
mammalian cells.23 Analogously, our results suggest 
that Ca(OH)2-containing endodontic filling materials 
were not genotoxic in U2OS cells.
A study by Chang et al.28 showed that CPC was 
toxic to cultured human pulp fibroblasts, but was 
incapable of inducing genotoxicity towards such 
cells. Here, test groups 6 and 7 contained CPC but 
did not appear to elicit any genotoxicity toward 
cultured U2OS cells.
Iodine, the main component of iodoform, induced 
morphologic transformation29 and sister chromatid 
exchanges but not unscheduled DNA synthesis (UDS) 
in Syrian hamster embryo cells.30 Iodoform-containing 
dental materials (experimental groups 2, 5 and 6) 
did not appear to elicit any DNA fragmentation in 
cultured U2OS cells.
Endodontic filling materials induce 
U2OS-cell COX-2 protein expression
No COX-2 protein expression following exposure of 
U2OS cells to ZnO + eugenol + FC or to Vitapex was 
apparent (Fig. 3). This suggests that these types of 
dental material do not elicit U2OS cell inflamma-
tion. This is consistent with the results of a rat-tooth 
study by Cotes et al.12 They suggested from the 
histology of the pulpal healing process after a pul-
potomy in rat teeth that FC combined with ZnOE 
showed the smallest pulpal inflammatory response. 
Furthermore, purified eugenol elicited less necro-
sis and inflammation than commercial eugenol, as 
was reported in an animal study.6 In this study, test 
group 3 produced little inflammation, which might 
be due to the purified eugenol content. 
Apart from experimental group 3, all other test 
groups contained a Ca(OH)2 component. Levels of 
COX-2 protein expressed by U2OS cells varied be-
tween the different study groups. Similar results 
were reported in a study by Nelson Filho et al.,31 
who demonstrated that when mast cells were ex-
posed to all Ca(OH)2-containing formulations, there 
was some degree of inflammatory response. Pitts 
et al.32 found that after placing material in the apex 
of a tooth, giant cells but no inflammatory cells were 
found adjacent to any remaining Ca(OH)2 particles. 
Segura et al.33 found that Ca(OH)2 inhibited mac-
rophage function and reduced the inflammatory 
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Fig. 2 DNA fragmentation assay results for U2OS cells 
treated with different formulations of pulpectomy mate-
rials. Lane 1 represents the marker, lane 2 the control 
group, lane 3 the Vitapex group, lane 4 the zinc oxide-
eugenol (ZnOE) + formocresol (FC) group, lane 5 the 
Ca(OH)2 + FC group, lane 6 the Ca(OH)2 + iodoform group, 
lane 7 the Ca(OH)2 + iodoform + camphorated parachloroph-
enol (CPC) group, and lane 8 the Ca(OH)2 + CPC group.
1 2 3 4 5 6 7 8




Fig. 3 Inflammation protein cyclooxygenase (COX)-2 
expression subsequent to U2OS cells being treated with 
different formulations of pulpectomy materials, as 
revealed by Western blot analysis. Lane 1 represents the 
control group, lane 2 the lipopolysaccharide group, lane 
3 the Vitapex group, lane 4 the zinc oxide-eugenol 
(ZnOE) + formocresol (FC) group, lane 5 the Ca(OH)2 + FC 
group, lane 6 the Ca(OH)2 + iodoform group, lane 7 the 
Ca(OH)2 + iodoform + camphorated parachlorophenol (CPC) 
group, and lane 8 the Ca(OH)2 + CPC group. 






Fig. 4 MAP kinase expression of U2OS cells treated with 
different formulations of pulpectomy materials for 24 
hours. Lane 1 represents the marker, lane 2 the control 
group, lane 3 the Vitapex group, lane 4 the zinc oxide-
eugenol (ZnOE) + formocresol (FC) group, lane 5 the 
Ca(OH)2 + FC group, lane 6 the Ca(OH)2 + iodoform group, 
lane 7 the Ca(OH)2 + iodoform + camphorated parachloroph-
enol (CPC) group, and lane 8 the Ca(OH)2 + CPC group.
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reaction in periapical tissue and in dental pulp 
when it was used in root canal therapy or in direct 
pulp capping and pulpotomy, respectively.
Iodoform paste is bactericidal to microorganisms 
in the root canal and loses only 20% of its potency 
over a 10-year period. Kawakami et al.34 found that 
Vitapex showed no necrotizing effect in rat subcu-
taneous tissue implantation. Similar results were 
noted in the present study; COX-2 protein expres-
sion did not occur in U2OS cells from the Vitapex 
group. Hence it would appear that Vitapex does 
not induce U2OS cell inflammation.
CPC is a tissue irritant.35 Llamas et al.36 reported 
that two different phenolic compounds inhibited 
adherence of rat peritoneal macrophages to the 
surface of proximate plastic tubes, suggesting that 
CPC may alter certain macrophage functions. We 
revealed that materials containing CPC elicited 
enhanced COX-2 protein expression by U2OS cells.
COX-2 expression related to MAP kinase 
expressions
No previous investigations relating to the effects 
on signaling pathways of cells stimulated with cer-
tain endodontic filling materials appear to have 
been published. Thus, it would be both appropriate 
and interesting to investigate the process of MAP 
kinase expression of cells exposed to various pri-
mary tooth endodontic filling materials.
When certain biomaterials come into contact 
with cells, the materials activate kinase signaling 
pathways of the cell. Here, levels of expression of 
ERK, p53 and caspase-3 protein kinase were evalu-
ated following treatment with various endodontic 
filling materials. Significant ERK expression by U2OS 
cells was noted for all test groups. Thus, we can 
conclude that the materials used stimulated U2OS 
cell proliferation and differentiation.
Both p53 and caspase-3 proteins were expressed 
by U2OS cells in all test groups. Although we previ-
ously demonstrated that these test materials elic-
ited various levels of cytotoxicity,5 we again note 
that the specific cell death mechanism responsible 
for such cytotoxicity is still unknown. The specific 
cell death mechanism may be related to activation 
of p53 and/or caspase-3 protein kinase in U2OS cells. 
After exposure to certain endodontic filling mate-
rials, U2OS cells may undergo apoptosis and pro-
ceed through certain mechanisms which ultimately 
result in cell death. Similar results were reported 
by Kitamura et al.37 who concluded that all Ca(OH)2-
containing dental capping agents were able to ac-
tively induce apoptosis during pulp wound healing.
Here, we observed no test material-elicited ge-
notoxicity in any of the experimental groups. 
Furthermore, we noted that p53 induced COX-2 
protein expression in all experimental groups ex-
cept test group 2. It was previously proposed that 
COX-2 is the ultimate downstream target of p53, 
and that COX-2 activation is mediated by p53’s in-
duction of heparin-binding epidermal growth factor-
like growth factor, which subsequently activates 
the Ras/Raf/MAPK pathway.38 In 2005, Choi et al.39 
reported that p53 induces COX-2 expression, and 
COX-2 inhibits p53- and genotoxic stress-induced 
apoptosis. Furthermore, it was also reported that 
COX-2 inhibits DNA damage-induced apoptosis 
through direct regulation of p53 function.
Conclusion
Here, we demonstrate that the tested endodontic 
filling materials were not genotoxic toward U2OS 
cells, but they caused COX-2 inflammatory protein 
expression in all tested groups except for the 
ZnOE + FC group. Furthermore, the study also showed 
that the cytotoxic mechanism following U2OS cell 
exposure to the tested endodontic filling materials 
was induction of cell apoptosis.
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